Recently, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis (advanced liver scarring) or with compensated cirrhosis. Bulevirtide is the first FDA-approved treatment for chronic HDV infection, a serious and life-threatening condition that can cause...
For years, we’ve been told lung cancer is mainly about smoking and genetic mutations. And while that’s true, it may not be the whole story. A growing body of research suggests something else plays a major role — inflammation. Let’s think about it this way. Mutations might strike the match, but inflammation may be the oxygen that keeps the fire burning. Every day, your body forms abnormal cells. Most of them are removed quietly by your immune system. So why do some grow into cancer? Researchers now believe chronic inflammation creates the kind of environment that allows mutated cells to survive, grow, and spread.
Testicular cancer is the most common cancer diagnosed in adolescent and young adult men, yet it remains one of the most treatable forms of cancer when detected early. Advances in treatment over the past several decades have transformed outcomes, with cure rates now exceeding 95% for many patients. Recent research is also highlighting new approaches that could further improve diagnosis, monitoring, and long-term survivorship.
https://www.youtube.com/shorts/q3rnQ28rYy8 Why do some people with acute low back pain recover quickly, while others develop chronic, long-term pain? A 2021 study published in JAMA Network Open explored this question—and uncovered how early treatment choices and personal risk factors can shape recovery outcomes.
Recently, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency’s efforts to advance sunscreen innovation. Bemotrizinol is the first new active ingredient added to the over-the-counter (OTC) sunscreen monograph since the late 1990s.
For the first time in more than two decades, the U.S. sunscreen market is getting a major update. The U.S. Food and Drug Administration (FDA) has expanded its list of approved sunscreen active ingredients to include bemotrizinol (BEMT) — marking the first new organic UV filter approved in the United States since 1999.
Dermatologists and skin cancer experts are calling this a significant step forward for sun protection in the U.S., bringing American formulations closer to what has long been available in Europe and other regions.